Included in the formulation
Included in the list (Order of the Government of the Russian Federation No. 2782-r of 30.12.2014):VED
АТХ:V.07.A.C Aids for blood transfusion
Pharmacodynamics:Anticoagulant. Binds Ca2+ (IV plasma factor of blood coagulability) and prevents hemocoagulation in vitro. Contained in the preparation dextrose serves as an energy substratum (serves as a food for blood cells); participates in the metabolism, enhances oxidation-reduction processes, improves the antitoxic function of the liver.
Pharmacokinetics:Dextrose
Absorption is fast. The maximum concentration is indicated 40 minutes after ingestion. Biotransformation occurs in the liver: through the formation of pyruvate or lactic acid is metabolized to water and carbon dioxide with the release of energy. Completely metabolized, not eliminated (presence in the urine - pathology).
Sodium citrate
After absorption, it is metabolized to bicarbonate, excreted by urine and increasing its volume and hydrogen index.
Indications:Preservation of blood.
XXI.Z40-Z54.Z51.3 Blood transfusion without a specified diagnosis
XXI.Z40-Z54.Z51.4 Preparatory procedures for subsequent treatment,not elsewhere classified
Contraindications:Increased bleeding, hypersensitivity.
Pregnancy and lactation:Category Food and Drug Administration (US Food and Drug Administration) not determined. Adequate and well-controlled studies in humans and animals have not been conducted. There is no information on the penetration into breast milk.
Dosing and Administration:In accordance with the "Instruction on the harvesting of preserved blood."
Side effects:Cramps, nausea, arrhythmia, chills, pollakiuria, allergic reactions, with a rapid infusion (infusion rate of more than 5 ml per minute) of a large number of blood components harvested using hemoconvant, there is a risk of citrated nephrotoxicity, hepatotoxicity, hypokalemia, with rapid massive transfusion of cold blood components - hypothermia with risk of arrhythmia, hypoxia.
Overdose:Hepatotoxicity, nephrotoxicity citrate. Treatment is symptomatic.
Interaction:You can not mix the blood components harvested using formulation with other agents.
Special instructions:Dextrose, which is contained in the drug, serves as a nutrient substrate. Shelf life of preserved blood at a temperature of 2-6 ° C is 21 days. Before use, check the integrity of the consumer container and the tightness of the container.